BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16309781)

  • 1. Wet age-related macular degeneration.
    Kulkarni AD; Kuppermann BD
    Adv Drug Deliv Rev; 2005 Dec; 57(14):1994-2009. PubMed ID: 16309781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Verma L; Das T; Binder S; Heriot WJ; Kirchhof B; Venkatesh P; Krebs I; Stolba U; Jahn C; Feichtinger H; Kellner L; Krugluger H; Pawelka I; Frohner U; Kruger A; Li W; Tewari HK
    Indian J Ophthalmol; 2000 Dec; 48(4):263-78. PubMed ID: 11340884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of neovascular age-related macular degeneration: past, present and future directions.
    Smith BT; Joseph DP; Grand MG
    Curr Opin Ophthalmol; 2007 May; 18(3):240-4. PubMed ID: 17435433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The molecular mechanisms of neovascular age-related macular degeneration].
    Miller DW; Joussen AM; Holz FG
    Ophthalmologe; 2003 Feb; 100(2):92-6. PubMed ID: 12589451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic physiology in age related macular degeneration.
    Stefánsson E; Geirsdóttir A; Sigurdsson H
    Prog Retin Eye Res; 2011 Jan; 30(1):72-80. PubMed ID: 20951826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity.
    Fletcher DC; Schuchard RA
    Optom Vis Sci; 2006 Mar; 83(3):178-89. PubMed ID: 16534460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S; Tatar O
    Prog Retin Eye Res; 2008 Jul; 27(4):372-90. PubMed ID: 18621565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular microcirculation blood flow in patients with age related macular degeneration treated with photodynamic therapy and transpupillary thermotherapy.
    Kubicka-Trzaska A
    Klin Oczna; 2007; 109(4-6):138-41. PubMed ID: 17725271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of age-related macular degeneration.
    Skaf AR; Mahmoud T
    Semin Ophthalmol; 2011 May; 26(3):181-91. PubMed ID: 21609231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N; Damico L; Shams N; Lowman H; Kim R
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related macular degeneration: a practical approach to a challenging disease.
    Bourla DH; Young TA
    J Am Geriatr Soc; 2006 Jul; 54(7):1130-5. PubMed ID: 16866687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration in Taiwan.
    Tsai TH; Yang CM; Yang CH; Ho TC; Huang JS; Chen MS
    Eye (Lond); 2007 Jun; 21(6):721-6. PubMed ID: 16543926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM
    Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A; La Heij E; Hendrikse F
    Ocul Immunol Inflamm; 2005 Feb; 13(1):3-11. PubMed ID: 15804763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies for neovascular age-related macular degeneration: state of the art.
    Donati G
    Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of choroidal neovascularization. Old concepts, new questions].
    Fauser S; Engelmann K; Krohne TU; Lappas A; Kirchhof B; Joussen AM
    Ophthalmologe; 2003 Apr; 100(4):300-5. PubMed ID: 12682762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.